Company: DMAAR
Filing Date: 2025-01-22
Form Type: POS AM
Source: 0001213900-25-005176
Chunk: 46

Company: Drugs Made In America Acquisition Corp.
Filing Date: 2025-01-22
Form: POS AM
Chunk 46
---
ution to investors in this offering. NTBV per share is determined by dividing our NTBV, which is our total tangible assets less total liabilities (including the value of ordinary shares that may be redeemed for cash), by the number of outstanding ordinary shares. See the section “ Dilution.” The below calculations (A) assume that (i) no ordinary shares are issued to shareholders of a potential business combination target as consideration or issuable by a post -businesscombination company, for instance under an equity or employee share purchase plan, (ii) no ordinary shares and convertible equity or debt securities are issued in connection with additional financing that we may seek in connection with an initial business combination, (iii) no working capital loans are converted into private placement units, as further described in this prospectus and (iv) no value is attributed to the rights, and (B) assume the issuance of 20,000,000 ordinary shares (or 23,000,000 ordinary shares if the over -allotmentoption is exercised in full), 9,857,143 founder shares (up to 1,285,714 of which are assumed to be surrendered and forfeited in the scenario in which the over -allotmentoption is not exercised in full) and 400,000 private shares (or 430,000 private units if the over -allotmentoption is exercised in full). Such calculations do not reflect any dilution associated with the conversion of rights as the rights are only convertible upon the consummation of our initial business combination. The following table illustrates the difference between the public offering price per unit and our NTBV per share, as adjusted to give effect to this offering and assuming redemption of our public shares at varying levels and the full exercise and no exercise of the over -allotmentoption:

| As of September 30, 2024 |                                                 |     |                |      |     |            |      |     |                |      |     |            |      |     |                |      |     |            |      |     |            |       |     |            |      |
|:-------------------------|------------------------------------------------:|:----|:---------------|-----:|:----|:-----------|-----:|:----|:---------------|-----:|:----|:-----------|-----:|:----|:---------------|-----:|:----|:-----------|-----:|:----|:-----------|------:|:----|:-----------|-----:|
| Offering                 
 Price of